Your browser doesn't support javascript.
loading
Cost-Effectiveness of New Direct-Acting Antivirals to Prevent Post-Liver Transplant Recurrent Hepatitis.
Cortesi, P A; Mantovani, L G; Ciaccio, A; Rota, M; Mazzarelli, C; Cesana, G; Strazzabosco, M; Belli, L S.
Afiliação
  • Cortesi PA; Research Centre on Public Health (CESP), University of Milan-Bicocca, Monza, Italy.
  • Mantovani LG; Department of Clinical Medicine and Surgery, University Federico II of Naples, Naples, Italy.
  • Ciaccio A; Department of Surgical and Interdisciplinary Medicine, University of Milan-Bicocca, Monza, Italy.
  • Rota M; Department of Health Sciences, Centre of Biostatistics for Clinical Epidemiology, University of Milan-Bicocca, Monza, Italy.
  • Mazzarelli C; Department of Hepatology and Liver Unit, Niguarda Hospital, Milan, Italy.
  • Cesana G; Research Centre on Public Health (CESP), University of Milan-Bicocca, Monza, Italy.
  • Strazzabosco M; Department of Surgical and Interdisciplinary Medicine, University of Milan-Bicocca, Monza, Italy.
  • Belli LS; Liver Center & Section of Digestive Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT.
Am J Transplant ; 15(7): 1817-26, 2015 Jul.
Article em En | MEDLINE | ID: mdl-26086300
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Complicações Pós-Operatórias / Transplante de Fígado / Análise Custo-Benefício / Hepatite C / Hepacivirus Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Complicações Pós-Operatórias / Transplante de Fígado / Análise Custo-Benefício / Hepatite C / Hepacivirus Idioma: En Ano de publicação: 2015 Tipo de documento: Article